SALT LAKE CITY--(BUSINESS WIRE)--Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that it presented positive preclinical ...
A global meta-analysis finds that anemia affects 37% of patients with inflammatory bowel disease, highlighting gaps in ...
Please provide your email address to receive an email when new articles are posted on . Researchers report positive results from a phase 1b/2a placebo-controlled study of DISC-0974, an ...
WATERTOWN, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
Panelists discuss how chronic kidney disease leads to iron deficiency anemia through a complex interplay of impaired iron absorption, increased hepcidin production driven by inflammatory cytokines, ...
Hosted on MSN
Anemia of Chronic Disease: What to Know
What Is Anemia of Chronic Disease? Anemia is a lack of healthy red blood cells with enough protein called hemoglobin. Hemoglobin requires iron to bring oxygen from the lungs to or ...
Chronic kidney disease (CKD) is frequently complicated by anaemia, predominantly due to an inadequate production of erythropoietin combined with disruptions in iron metabolism and chronic inflammation ...
The investigational monoclonal antibody DISC-0974 shows early promise for treating functional iron deficiency in patients with nondialysis CKD and anemia. An anti-hemojuvelin antibody is being ...
In this study, both anemia and chronic kidney disease were highly prevalent among HF patients discharged from two university hospitals and independently associated with an increased risk of dying in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results